ArriVent BioPharma Up Nearly 11%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones

Jan 23

ArriVent BioPharma, Inc. (AVBP) is currently at $25.33, up $2.45 or 10.71%

--Would be highest close since June 16, 2025, when it closed at $25.42

--On pace for largest percent increase since Aug. 26, 2024, when it rose 12.65%

--Currently up three consecutive days; up 21.43% over this period

--Best three-day stretch on record (Based on available data back to Jan. 26, 2024)

--Up 25.89% month-to-date

--Up 25.89% year-to-date

--Down 28.91% from its all-time closing high of $35.63 on Nov. 7, 2024

--Down 7.05% from 52 weeks ago (Jan. 23, 2025), when it closed at $27.25

--Down 13.4% from its 52-week closing high of $29.25 on Feb. 5, 2025

--Up 55.4% from its 52-week closing low of $16.30 on April 8, 2025

--Traded as high as $26.00; highest intraday level since Feb. 26, 2025, when it hit $26.32

--Up 13.64% at today's intraday high; largest intraday percent increase since Aug. 26, 2024, when it rose as much as 15.66%

All data as of 3:06:36 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 22, 2026 15:10 ET (20:10 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2605414471"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605414471\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605414471?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 04:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605414471","market":"other","top_or_hot":-1,"title":"ArriVent BioPharma Up Nearly 11%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/AVBP\">ArriVent BioPharma</a>, Inc. (AVBP) is currently at $25.33, up $2.45 or 10.71% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since June 16, 2025, when it closed at $25.42 \n</p>\n<p>\n     --On pace for largest percent increase since Aug. 26, 2024, when it rose 12.65% \n</p>\n<p>\n     --Currently up three consecutive days; up 21.43% over this period \n</p>\n<p>\n     --Best three-day stretch on record (Based on available data back to Jan. 26, 2024) \n</p>\n<p>\n     --Up 25.89% month-to-date \n</p>\n<p>\n     --Up 25.89% year-to-date \n</p>\n<p>\n     --Down 28.91% from its all-time closing high of $35.63 on Nov. 7, 2024 \n</p>\n<p>\n     --Down 7.05% from 52 weeks ago (Jan. 23, 2025), when it closed at $27.25 \n</p>\n<p>\n     --Down 13.4% from its 52-week closing high of $29.25 on Feb. 5, 2025 \n</p>\n<p>\n     --Up 55.4% from its 52-week closing low of $16.30 on April 8, 2025 \n</p>\n<p>\n     --Traded as high as $26.00; highest intraday level since Feb. 26, 2025, when it hit $26.32 \n</p>\n<p>\n     --Up 13.64% at today's intraday high; largest intraday percent increase since Aug. 26, 2024, when it rose as much as 15.66% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 3:06:36 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 22, 2026 15:10 ET (20:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ArriVent BioPharma Up Nearly 11%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArriVent BioPharma Up Nearly 11%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-23 04:10</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/AVBP\">ArriVent BioPharma</a>, Inc. (AVBP) is currently at $25.33, up $2.45 or 10.71% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since June 16, 2025, when it closed at $25.42 \n</p>\n<p>\n     --On pace for largest percent increase since Aug. 26, 2024, when it rose 12.65% \n</p>\n<p>\n     --Currently up three consecutive days; up 21.43% over this period \n</p>\n<p>\n     --Best three-day stretch on record (Based on available data back to Jan. 26, 2024) \n</p>\n<p>\n     --Up 25.89% month-to-date \n</p>\n<p>\n     --Up 25.89% year-to-date \n</p>\n<p>\n     --Down 28.91% from its all-time closing high of $35.63 on Nov. 7, 2024 \n</p>\n<p>\n     --Down 7.05% from 52 weeks ago (Jan. 23, 2025), when it closed at $27.25 \n</p>\n<p>\n     --Down 13.4% from its 52-week closing high of $29.25 on Feb. 5, 2025 \n</p>\n<p>\n     --Up 55.4% from its 52-week closing low of $16.30 on April 8, 2025 \n</p>\n<p>\n     --Traded as high as $26.00; highest intraday level since Feb. 26, 2025, when it hit $26.32 \n</p>\n<p>\n     --Up 13.64% at today's intraday high; largest intraday percent increase since Aug. 26, 2024, when it rose as much as 15.66% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 3:06:36 PM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 22, 2026 15:10 ET (20:10 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVBP","symbol_name":"ArriVent BioPharma","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2605414471","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605414471","pubTimestamp":1769112600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"ArriVent BioPharma, Inc.  is currently at $25.33, up $2.45 or 10.71%. --Would be highest close since June 16, 2025, when it closed at $25.42. --On pace for largest percent increase since Aug. 26, 2024, when it rose 12.65%. --Currently up three consecutive days; up 21.43% over this period. --Down 28.91% from its all-time closing high of $35.63 on Nov. 7, 2024. --Down 7.05% from 52 weeks ago , when it closed at $27.25. --Up 55.4% from its 52-week closing low of $16.30 on April 8, 2025. --Traded as high as $26.00; highest intraday level since Feb. 26, 2025, when it hit $26.32. --Up 13.64% at today's intraday high; largest intraday percent increase since Aug. 26, 2024, when it rose as much as 15.66%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVBP":"ArriVent BioPharma","BK4139":"生物科技"},"translate_title":"ArriVent BioPharma上涨近11%，有望创2024年8月以来最大百分比涨幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVBP":1.5},"content_text":"ArriVent BioPharma, Inc. (AVBP) is currently at $25.33, up $2.45 or 10.71% \n\n\n \n\n\n     --Would be highest close since June 16, 2025, when it closed at $25.42 \n\n\n     --On pace for largest percent increase since Aug. 26, 2024, when it rose 12.65% \n\n\n     --Currently up three consecutive days; up 21.43% over this period \n\n\n     --Best three-day stretch on record (Based on available data back to Jan. 26, 2024) \n\n\n     --Up 25.89% month-to-date \n\n\n     --Up 25.89% year-to-date \n\n\n     --Down 28.91% from its all-time closing high of $35.63 on Nov. 7, 2024 \n\n\n     --Down 7.05% from 52 weeks ago (Jan. 23, 2025), when it closed at $27.25 \n\n\n     --Down 13.4% from its 52-week closing high of $29.25 on Feb. 5, 2025 \n\n\n     --Up 55.4% from its 52-week closing low of $16.30 on April 8, 2025 \n\n\n     --Traded as high as $26.00; highest intraday level since Feb. 26, 2025, when it hit $26.32 \n\n\n     --Up 13.64% at today's intraday high; largest intraday percent increase since Aug. 26, 2024, when it rose as much as 15.66% \n\n\n \n\n\n     All data as of 3:06:36 PM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2026 15:10 ET (20:10 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}